Apparently ATH has a second trial going on called ATH434-202 in patients with advanced MSA. There are 10 patients enrolled in total with treatment going for 12 months. The study is an open-label, single arm study in individuals with more advanced MSA. According to the web site, the study will be completed by the 14th Feb.
The results announced today were for the ATH434-201 study which was in early stage MSA patients. Does anyone have any idea of when the results of the -202 study will be announced?
Ann: Positive ATH434 Phase 2 Results Led By Clinical Efficacy, page-115
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $128.9M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $188.8K | 13.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 20724621 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 1182673 | 6 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |